[Federal Register: July 25, 2005 (Volume 70, Number 141)]
[Notices]
[Page 42558]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr25jy05-48]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control
Special Emphasis Panels (SEP): Reducing Racial and Ethnic
Disparities in Childhood Immunization, RFA IP 05-087; Influenza
Vaccination of Healthcare Workers in Hospitals, RFA IP 05-089;
Expanding Utilization of Pro-Active Pharmacist Pneumococcal Vaccination
Programs, RFA IP 05-092; and CDC Disparities in Elderly Pneumococcal
Vaccination, RFA IP 05-093.
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting:
Name: Disease, Disability, and Injury Prevention and Control
Special Emphasis Panel (SEP): Reducing Racial and Ethnic Disparities
in Childhood Immunization, RFA IP 05-087; Influenza Vaccination of
Healthcare Workers in Hospitals, RFA IP 05-089; Expanding
Utilization of Pro-Active Pharmacist Pneumococcal Vaccination
Programs, RFA IP 05-092; and CDC Disparities in Elderly Pneumococcal
Vaccination, RFA IP 05-093.
Times and Dates: 8 a.m.-5 p.m., August 9, 2005 (Closed).
Place: Renaissance Concourse Hotel, One Hartsfield Centre
Parkway, Atlanta, GA 30354, Telephone Number (404) 209-9999.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters to be Discussed: The meeting will include the review,
discussion, and evaluation of applications received in response to:
Reducing Racial and Ethnic Disparities in Childhood Immunization,
RFA IP 05-087; Influenza Vaccination of Healthcare Workers in
Hospitals, RFA IP 05-089; Expanding Utilization of Pro-Active
Pharmacist Pneumococcal Vaccination Programs, RFA IP 05-092; and CDC
Disparities in Elderly Pneumococcal Vaccination, RFA IP 05-093.
Contact Person for More Information: H. Mac Stiles, PhD, D.D.S,
M.P.H., Scientific Review Administrator, 24 Executive Park, NE.,
Mailstop E74, Atlanta, GA 30333, Telephone (404) 498-2530.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: July 19, 2005.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 05-14578 Filed 7-22-05; 8:45 am]
BILLING CODE 4163-18-P